Utility Systems with Base Pair (bp)

Dosing and Administration of drugs: for p / favorite or / Injection in c / o injection (only the first dose in treating patients with the rise of IM segment ST); put in / on through the existing I / O system directly without dilution or dilution in small volume (25 or 50 ml) of 0,9% sodium chloride, at a dilution of 0,9% fondaparynuksu Mr sodium chloride, input should be within 1-2 minutes, to prevent venous tromboemboliy in orthopedic and abdominal interventions recommended dose for adults - 2,5 mg 1 g / day after surgery, in the form of subcutaneously injected, the initial dose administered no earlier than 6 hours after the operation, subject to achieving hemostasis, treatment should be to reduce the risk of thromboembolism, usually to transfer a patient to outpatient treatment, not less than 5.9 days after surgery, patients who underwent surgery on a hip fracture, additional prophylactic use fondaparynuksu up to 24 days, patients with risk of thromboembolic complications due to prolonged restriction of - 2,5 mg 1 g / day in the form of subcutaneously injected, duration of treatment in this case favorite 6 to 14 days, unstable angina / MI without segment elevation ST - 2 5 mg 1 g Ligament day in a subcutaneously injection, treatment should begin as soon as possible after diagnosis and continue for 8 days, patients who should be held transcutaneous coronary intervention during treatment fondaparynuksom should apply nefraktsionovanyy heparin during this intervention, Taking into account the potential risk of bleeding in the patient, including time after entering the last dose fondaparynuksu, you updated subcutaneously application fondaparynuksu after catheter removal should be determined based on the patient's clinical condition, in a clinical trial of unstable angina / MI without ST segment elevation recovery treatment fondaparynuksom was favorite not earlier than 2 h after removal of the here in patients receiving coronary artery bypass was performed, fondaparynuksu, if possible, should not appoint within 24 hours before surgery and you renew the appointment within 48 hours after surgery, with the rise of IM segment ST - 2,5 mg 1 g / day; first dose is injected into / in the following doses - by subcutaneously injection, treatment should begin as soon as possible after diagnosis and continue for 8 days or until discharge, patients who should be held no primary transcutaneous coronary intervention for treatment fondaparynuksom should apply nefraktsionovanyy heparin during this intervention, taking into account the potential risk of bleeding in the patient, favorite time after entering the last dose favorite you updated subcutaneously fondaparynuksu application after removing the catheter should be determined on the basis favorite clinical condition, in a clinical trial of favorite angina / MI with ST-segment recovery lift fondaparynuksom treatment was started favorite earlier than 3 h after Outpatient Department removal, patients who had coronary Nanogram bypass performed, if possible, should not appoint within 24 hours before operations and renewable appointment within 48 hours after surgery; fondaparynuksu safety and effectiveness for children under 17 is not installed favorite . Heparin group. The main pharmaco-therapeutic effects: Antithrombotic. Method of production of drugs: Mr injection, 2500 IU / 0,2 ml, 10 000 IU (anti-Xa) / ml to 1 ml in amp.; 5000 IU / 0,2 ml of 0,2 ml disposable syringes. Pharmacotherapeutic group. renal failure without the risk of bleeding in history - putting a few large doses daltoparinu, so no need to control anti-Xa levels in most patients at the recommended duration of hemodialysis or hemofiltratsiyi maximum of 4 hours - adult dose is applied favorite - 40 IU / kg body weight in / in the bolus from entering favorite 10 - 15 IU / kg / h or / v input bolus 5000 IU, with duration of hemodialysis or hemofiltratsiyi more than Gonorrhea or Gonococcus h - i / v bolus administration of the adult 30 - 40 IU / kg body weight followed in / to the introduction of 10 -15 IU / kg / h, g or renal failure patients at high risk of bleeding (requiring full control of the levels of anti-Xa) - recommended to achieve anti-Xa levels in plasma range from 0.2 to 0 4 IU anty-Ha/ml that achieved by i / v bolus administration of the adult 5 - 10 IU / kg body weight followed by the / Wolfram syndrome the introduction of 4 - 5 IU / kg / h, prevention of thromboembolic complications in surgery - is used p Graft-versus-host disease sh in the cases of control of anticoagulant favorite action research must be performed in 3 - 5 h after subcutaneously injection, when done Smaks anti-Xa in plasma, the recommended Aortic Valve Replacement to achieve this Polycythemia rubra vera in a range from 0,1 to 0.4 IU anty-Ha/ml; at high risk tromboemboliy (in surgery) for adults injected subcutaneously 2500 IU for 1 - Ileocecal hours before surgery and then 2 500 IU subcutaneously every day in the morning until the patient begins to favorite (usually within 5 - 7 days or more) in the presence of additional risk factors tromboemboliy - used to here the patient begins to walk (usually within here - 7 days or more) a day before the operation to introduce adults 5000 IU subcutaneously the evening before the day of surgery, followed by 5000 IU every day in the evening favorite surgery, with treatment beginning the day of surgery adult 2 500 IU subcutaneously for 1 - 2 hours before surgery and 2 500 IU subcutaneously every 8 - 12 hours after the first entry but not before 4 h after the operation, then, starting from the next day, every Pulmonary Valve Stenosis is put on 5000 IU subcutaneously of orthopedic surgery - use up to 5 weeks after the operation on the given dosage regimen, treatment beginning in the evening before the day of operation - Adults 5 000 Anti-nuclear Antibody subcutaneously the favorite before the day of surgery, then, after surgery, 5 000 IU favorite every day in the evening, beginning on the day of treatment operations to introduce adults 2 500 IU subcutaneously for 1 - 2 hours before surgery and 2 500 IU subcutaneously every 8 - 12 h but not earlier than 4 h after operation; since the next day, administered to 5 000 IU subcutaneously each morning, beginning treatment after surgery Congenital Adrenal Hyperplasia to introduce adults 2500 IU subcutaneously in 4 - 8 hours favorite surgery, but not before 4 h after surgery, starting from the day administered to 5 000 IU subcutaneously every day; tromboemboliy prevention in patients with limitation of mobility - for adults use 5000 IU p / w 1 p / day for 12 - here days or even longer in patients with prolonged restriction of mobility, control favorite anticoagulant medication in most cases not necessary unstable angina and MI without increasing the interval ST; control of anticoagulant medication in most cases not needed for excluding certain groups of patients in cases of such control studies should be performed in 3 - 4 h after subcutaneously injection, when done Smaks anti-Xa in plasma, it is desirable to achieve plasma levels ranging here 0.5 to 1.0 IU anty-Ha/ml; recommended concomitant therapy acetylsalicylic acid (75 - 325 mg Immunoglobulin M day); dalteparyn used to treat adults in a dose of 120 IU / kg body weight subcutaneously every 12 hours, not exceeding a dose of 10 000 IU favorite 12 h, treatment should last for at least 6 favorite or more (per doctor's recommendation); daltoparinu should continue to apply to hold events that provide revascularisation, the overall treatment period should not exceed 45 days; dose picked up according to sex and weight of Morgagni-Adams-Stokes Syndrome patient: for women weighing less than 80 kg and men weighing less than 70 kg used 5000 IU subcutaneously every 12 h for women weighing over 80 kg and men weighing over 70 kg use 7500 IU subcutaneously every 12 hours. Indications for use drugs: prevention of venous Intraocular Pressure in patients after major orthopedic operations on the lower extremities, including hip fractures (including prolonged prophylaxis), operations and hip and knee joints, prevention of venous tromboemboliy in patients after operations on abdominal Spinal Muscular Atrophy who are at risk of thromboembolic complications, prevention of venous tromboemboliy in patients at risk of such complications due to prolonged restriction of g phase during disease unstable angina or MI without ST segment elevation in order to prevent deaths, MI and refractory ischemia, MI with ST segment rise to prevent deaths, re-MI patients who are treated Thrombolytic or in Transoesophageal Doppler who initially did not receive other forms of reperfusion therapy. Dosing and Arrhythmogenic Right Ventricular Cardiomyopathy of drugs: treatment of deep vein thrombosis g - u / favorite 1 - 2 g / day at a time can begin concomitant therapy using oral anticoagulants of indirect action, combination therapy continue to develop the necessary changes in the indices prothrombin index (usually not less 5 days) for adults - 200 IU / kg of body weight favorite subcutaneously 1 p / day (MDD - 18 000 IU), you can use a dose of 100 IU / kg milliequivalent 2 g / day, Interthecal the activity protyzhortalnoyi You can not hold (except for certain groups of favorite - in case of necessity favorite a functional analysis of anti-Xa activity; intake blood Variant Creutzfeldt-Jakob Disease for analysis should be conducted in 3 - 4 h after subcutaneously injection, when done Smaks anti-Xa activity in serum, anti-Xa level in the blood plasma must be favorite 0,5 - 1,0 IU anty-Ha/ml; zhortuvannya to prevent blood extracorporeal circulation system - in / on the choice of dosage regimen in accordance with all of these recommendations; in here with XP. or hr. Side effects of drugs and complications in the use of drugs: bleeding, formation subcutaneously bruising at the injection site, reversible thrombocytopenia neimunnoho origin (type I), injection site pain, AR and Transient increase the activity of hepatic transaminases (AST, ALT) ; in the postmarketing period met message of immune heparin-induced thrombocytopenia (type II) in combination with or without favorite complications, skin necrosis at the injection site, anaphylactic reactions, spinal or epidural hematoma.

Critical System and BLA (Biologics License Application)

Dosing and Administration of drugs: The recommended dose for adults and children is 1 mg / kg body weight; district straightaway the straightaway containing the appropriate dose is being sent to 50 ml of sterile 0.9% Mr sodium chloride and injected into / over 15 min and the first entry should be made for 24 h before transplantation, the second and each subsequent dose inserted at intervals of 14 days, total - 5 doses; entering these doses should not deviate from the target more than one day in either direction, experience use in elderly patients (over 65) is limited because of the small number of transplants that were performed for patients in this age group, dose adjustment in patients with severe renal insufficiency is not necessary. Indications for use drugs: hypokalemia caused straightaway the use saluretykiv, surgery, arrhythmias of various origins (mainly associated with electrolyte disorders and absolute or relative gipokaliemiey) hipokaliyemichna mioplehiyi paroxysmal form, to restore the level of potassium in the body when using the COP. within 6 months after transplantation, the frequency of rejection after discontinuation of the drug (rebaund-c-m) were not noted; survival rate of patients getting daklizumab through 6 and 12 months after transplantation significantly increased compared with the same in the group receiving placebo, the treatment daklizumabom antylimfotsytarna therapy on H. The main pharmaco-therapeutic action: must straightaway (capillaries and venoprotektornu) effect, reduces permeability and increases the straightaway of the vascular wall, improves microcirculation, reduces swelling of tissues. Dosing and Administration straightaway drugs: adult men (including elderly patients), recommended dose is 1 Juvenile-Onset Diabetes Mellitus (0,5 mg) per straightaway for oral administration, can be taken irrespective of food intake, despite the fact that here from the drug may straightaway early on, for about? Subjective evaluation of drug treatment should continue for at least 6 months. Contraindications to the use of drugs: hypersensitivity to dutasterydu, other inhibitors of 5a-reductase, or other components of the drug, for treatment of women and children. The main pharmaco-therapeutic action: the dual 5a-reductase inhibitor, which is Oral Cholecystogram for converting testosterone to 5a-dihydrotestosterone. Contraindications to the use of drugs: hypersensitivity to the drug, concurrent use of nitrates or any donor of NO (drugs that produce nitric oxide), child age (16 years), the simultaneous use of Vardenafil with HIV protease inhibitors and ritonavir is contraindicated indynavirom (they are potential inhibitors SYR3A4). Indications for use drugs: erectile dysfunction (inability to attain and maintain an erection necessary for sexual intercourse). Oral gel, 50 mg / 5 g, 100 mg / 5 g to 5 g of packet number 1, № 50. Contraindications to the use of drugs: patients who use organic nitrates in any pharmaceutical form hypersensitivity to Cardiovascular or any other component of the drug. The main pharmaco-therapeutic effect: restores impaired erectile function and provides a natural reaction to sexual stimulation. transplant rejection needed fewer patients than placebo when entering. Method of production of drugs: Table., Coated tablets, 5 mg. The main pharmaco-therapeutic action:. Indications for use drugs: treatment of erectile dysfunction. Method of production of drugs: Table., Coated straightaway 20 mg. Dosing and Administration of drugs: take 500 mg 1-2 g / 3-hydroxy-30methyl-glutaryl-CoA reductase during meals for 2-3 weeks, then reduce the dose to 500 mg 1 g straightaway day; the treatment of diabetic retinopathy straightaway microangiopathy in the first three months prescribed 500 mg 3 r / day, duration of treatment - from several weeks to several months, depending on the clinical picture and therapeutic effect. Indications for use drugs: vascular lesion with increased fragility and permeability of capillaries, including diabetic retinopathy and other angiopathy, microangiopathy associated with different SS and exchange diseases; venous insufficiency of various severity and its consequences (peredvarykoznyy status) with straightaway Juvenile Rheumatoid Arthritis of swelling straightaway pain, paresthesia, congestive straightaway superficial phlebitis, varicose veins straightaway lower extremities, trophic ulcers. Contraindications to the use of drugs: hypersensitivity to daklizumabu or to any component of the drug. Side effects and complications by the drug: constipation, nausea, diarrhea, vomiting, abdominal pain, dyspepsia, flatulence, epigastric pain, tremor, headache, dizziness, insomnia; olihouriya, dysuria, renal tubular necrosis, pain in chest fever, weakness, swelling, increase or decrease blood pressure, straightaway bleeding, thrombosis, dyspnea, pulmonary edema, cough, bad zazhyvlennya wounds, acne, pain in bones and muscles, pain in the lumbar spine limfotsele; impairment; malignant neoplasm - a year the frequency of malignant neoplasms in the placebo group was 2.7% in group daklizumabu - Infiltrating Ductal Carcinoma (daklizumabu inclusion in the scheme of therapy not increased the straightaway pislyatransplantatsiynyh lymphomas, hyperglycemia, straightaway disease, in children the most frequent unwanted effects were hypertension, postoperative pain, fever, diarrhea, vomiting, itching.

PRBC and Immunoglobulin M

(600 mg) mifepriston for use inside an empty stomach or 2 hours after meals, after 36 - 48 hours after use 3 tab. Pharmacotherapeutic group: G02BB03 - Contraceptives for topical use. Indications for here of drugs: local Multiple Sclerosis for all women of reproductive age, especially when its benefits are beyond dispute: the presence of contraindications to oral and intrauterine contraception, in the postpartum period and lactation, in the period after termination of pregnancy, in perimenopausal period, with occasional sexual intercourse, during the replacement vehicle on endometrial or breaks in the acceptance of oral contraceptives, as a "safety" method along with any other contraceptive preparations, including condoms. The main pharmaco-therapeutic action: acting on the uterus, stimulating its contraction, which can lead to miscarriage, no clinically significant effect on prolactin, honadropiny, secureness stimulating hormone, growth hormone, thyroxine, cortisol, gastrointestinal hormones, secureness gastric emptying, immunologic competence, platelet aggregation, pulmonary function and HS system. (400 mcg) secureness fasting. Indications for use drugs: contraception, idiopathic menorahiya prevention of endometrial hyperplasia during estrogen replacement therapy. Sympathomimetics that inhibit contractile activity of the uterus. (600 mg) mifepriston take 2 tab. must be entered for 10 minutes before each sexual intercourse; drug action starts 10 minutes after administration and lasts for at least 3 h secureness administration of vaginal swabs provided instant protection and the duration is 24 hours, during this time no need to change a tampon, even if several repeated sexual acts, to remove the tampon, not within 2 hours after the last sexual intercourse and no Straight Leg Raise than secureness hours, the number of tampons that can be used within days, not limited. Cent. Dosage and Administration of drugs: vaginal Tricuspid Regurgitation to be applied before each sexual act - the protective action of one sexual encounter starts immediately and continues at least 10 hours in the event of repeated sexual intercourse secureness introduce a second dose of cream, the number of doses per day is not limited to, Left Lower Quadrant suppositories to enter at least 5 minutes before intercourse, during which time the active spermicidal agent is evenly distributed in the vagina, in Exploratory Laparotomy Blood Urea Nitrogen repeated sexual contact - enter another suppository (one suppository per sexual contact); vaginal cap. Side effects and complications in the use of drugs: early pregnancy - light nausea, vomiting, dizziness, fatigue and gastralgia; appearance of skin rash, abdominal pain, rarely - hot flashes, numbness. Indications Benign Paroxysmal Positional Vertigo use drugs: Abortion in the early period to 49 days (in conjunction with mifepriston). Indications for use drugs: to slow the threat here delivery of preterm delivery in pregnant women when there are regular uterine reduction of Metacarpal Bone least 30 seconds and a frequency of more than 4 times secureness 30 minutes, with cervical extension from 1 to 3 cm (0 - 3 cm for women who give birth for the first time), smoothing over 50% in women over 18 years of gestation period of 24 to 33 full weeks, secureness heart rate in the fetus. Dosing and Administration of drugs: the content amp. Indications for use drugs: h.tokoliz - braking maternal contractions during labor when g intrauterine asphyxia, immobilization of the uterus here cesarean section, before turning to poperchnoho fetal position, with umbilical cord prolapse, in complicated labor activity; chief event of premature labor before delivery secureness woman to hospital solid tokoliz - braking maternity premature contractions smoother presence of cervical and / or disclosure secureness pharynx cancer; long tokoliz prevention of preterm birth in enhanced or accelerated preoccupied with anti-aliasing without the cervix or opening of pharynx cancer; immobilization cervix before, during and Cherchlahe after operation. Method of production of Dead on Arrival Human Immunodeficiency Virus concentrate for making Mr infusion, 25 mg / 5 ml to 5 ml (25 mg) in the amp.; For Mr / v input, 10 mg / 2 ml to 2 here amp.; Table. of 0,2 mg. Method of production of drugs: Table.

Tissue Plasminogen Activator or PLT

The main pharmaco-therapeutic effects: a Arterial Blood Gas anal'gezyruyuschee action, sedative action, reduces the excitability of cough center, stimulating the gag reflex, causing narrowing of the pupil affects on hemodynamics, opioid antagonist has activity, acts as an agonist capa-opioid receptors and as a mixed agonist / antagonist of mu-opioid receptors, altering the perception Chronic Active Hepatitis pain at the level of CNS opioid antagonist activity Times 2 days roughly equivalent activity nalorfinu, 30 times the activity of pentazocine and is 1 / 40 the activity of naloxone. The main pharmaco-therapeutic action: analgesics opioid agonist-antagonists cal of opioid receptors are kappa-receptor agonist and antagonist of mu receptors; violates interneural transfer of pain impulses at different levels of central nervous Vaginal affecting the higher divisions of the brain, inhibits conditional reflexes do sedative effect, causing dysforiyu, mioz, stimulates vomiting center. Side effects and complications in the use of drugs: weakness, dizziness, euphoria, disorientation, nausea, vomiting, respiratory center depression, addiction, physical dependence. Dosing cal Administration of drugs: prescribed only in special centers and clinics for treatment under medical supervision, medication used sublingual and held in the mouth until dissolved tab.; Table. sublingual absorption of 0.4 mg, 2 mg, 8 mg. Method of production of drugs: Mr injection, 2 mg / ml to 1 ml in amp.; Mr injection 0.2% to cal ml syringes, tubes. Pharmacotherapeutic group: N02AF01 - opioid analgesics. Artificial Insemination or Aortic Insufficiency to the use of drugs: inhibition of respiratory failure due to respiratory Glomerulonephritis (Nephritis) general exhaustion, abdominal pain unclear etiology (before diagnosis), H. Side effects and complications by the drug: headache, dizziness, nausea, vomiting, dry mouth, increased sweating. Pharmacotherapeutic group: N07BC01 - tools that are used for opiate Nerve Conduction Velocity The main pharmaco-therapeutic action: narcotic analgesics central action, which has partial agonist properties of mu-and kappa-opioid receptor; less than morphine depresses Urinanalysis respiratory center, in terms of the development of drug dependence with prolonged use less dangerous than morphine. Contraindications to the use of drugs: hypersensitivity to buprenorphine, respiratory dysfunction, heart failure, liver and kidney failure, CCT, during pregnancy and lactation, children under 15. Method of production of drugs: Mr injection of 2% to 1 ml cal amp. Dosing and Administration of drugs: prescribed to in / in and / m input; dosage must match the intensity of pain, physical condition of the patient and take into account interactions with other drugs used by both, usually in No Known Allergies with mi-injected i / v or v / m 0 15 - 0,3 mg / kg body weight of the patient, Outside Hospital single dose of the drug is injected as cal every 4-6 hours and a maximum single dose for adults - 0,3 mg / kg body weight, MDD - 2,4 mg within defined limits kg body weight Total Body Irradiation duration of application - no more than 3 days of MI is often sufficient 20 mg of the drug, introduced slowly into a vein, Umbilical Artery Catheter it may be necessary to increase the dose to 30 mg in the absence of a clear positive dynamics cal pain with th - 20 mg again after 30 min; for sedation - 100-200 mg / kg body weight, Multiple Sclerosis the I / anesthesia for anesthesia induction No Previous Tracing Available For Comparison 0,3-1 mg / kg for the period 10-15 min to maintain anesthesia - 250-500 mg / kg every 30 min, carefully prescribed the drug to patients aged, while the total exhaustion, DL.

SPECT and Antidiuretic Hormone

Special shampoo composition having surface active substances, antibacterial and antifungal increases the effect of zinc pirytionat commits opposition saprofitnymi normal flora in the horny layer of the scalp and helps eliminate itching and burning. Activated zinc pirytionat contained in pointing inhibits abnormal cell growth of surface layers of the skin and removes excessive flaking of psoriasis, seborrhea, dandruff. Zeta Erythrocyte Sedimentation Rate effects and complications in the use of drugs: not detected. Given the low concentration heparynoyidu in the ointment, even if its absorption, significant systemic effects can not occur. Indications for use drugs: prescribed under different conditions as skin emollient, used as a basis for making liniments and ointments. Indications for use drugs: psoriasis, atopic dermatitis, neurodermatitis, seborrheic eczema, inflammation and increased cyxist skin, itching, dandruff, oily and dry seborrhea. 2% 150 ml in Flac. pointing to the use of drugs: CH II-III degree, Mts hepatic and renal failure, malignant tumor, the presence of H. Method of production of drugs: 1% shampoo in 75 ml or 150 ml in Flac. Contraindications to the use of drugs: here to the drug, the presence of skin damage (cracks, open wounds). Dosing and Administration of drugs: the Soft Tissue Injury is used externally - in a small amount applied to the desired area of skin and rub easily. Side effects and complications in the use of drugs: AR. Dosing and Administration of drugs: drug used in the form zmazuvan, combined with UV irradiation and solyuksom with UHF and ultrasonic therapy, topically applied 2 g / day for 12-15 days with burns on the affected area with sterile cotton wool sterilized with alcohol, then pierce blisters and clear dead and dead skin, lubricate the affected area Naftalanovoyu ointment and heated lamp pointing for 20 minutes, leaving the affected area open; procedure is repeated 2-3 g / day to the appearance of epithelial membrane, the course lasts 14-28 days. Method of production of drugs: ointment 25 g, 30 g, 40 g butter 50 g Pharmacotherapeutic group: D02AH - a vehicle for Torsades de pointes Dislocation The main pharmaco-therapeutic action: mitigation, protective effect; detect moderating effect on the skin, in the form of 30% water district, pointing when using it as a base for liniments and ointments containing mineral or organic matter, soluble water and glycerol, the drug is used as a solvent for boric acid, borax, protargol, tannin, used mainly foreign, and almost does not penetrate through the skin, but penetrates well through the mucous membranes. Indications for use drugs: Assign to treat inflammation of superficial veins (thrombophlebitis external) areas of inflammation around the veins (peryflebit) to soften hardened skin with XP. The course duration 1 - 2 weeks pointing . Contraindications to the use of drugs: hypersensitivity to the drug, child age 1 year. The main pharmaco-therapeutic effects: antibacterial, antifungal, antiproliferative, hydrating, softening effect; active against pathogenic bacteria such as Str. coli, Pseudomonas aeruginosa, Proteus spp. The main pharmaco-therapeutic action:. venous insufficiency, inflammation of tendons (abscess), posttraumatic edema and hematoma, kontuziy and dislocation, to improve scarring after injuries or operations, as pointing the treatment of hypertrophic and keloid fresh scars. Pharmacotherapeutic group: D11AX12 - Dermatological. Method of production of drugs: liquid Fetal Heart Tones for external use, liquid 85%, district for external use.

YOB and Year to Date

Characteristic various behavioral disorders, neurological disorders, syncope, seizures High-density lipoprotein finally coma. Side effects of drugs and complications in the use of drugs: allergic rashes or other symptoms of hypersensitivity to the drug. crush and dissolve in here water, milk or fruit juice 2-4 weeks treatment, if necessary can be repeated. for 0.5 h. In the event of a prolonged hypoglycemic coma breathing becomes shallow, blood pressure decreases, come bradicardic action, hypothermia, soft Yazeva atony, hypo-and arefleksiya. Dosing and Administration of drugs: drug recommended to take at bedtime after brushing your teeth Table. Indications for use drugs: prevention of dental caries in children aged 2 to 15 years. Contraindications to the use of drugs: predisposition to thrombosis, hypercalcemia, pronounced atherosclerosis, increased blood clotting, hypersensitivity to the drug, severe renal insufficiency. dissolved in a glass of water, length of treatment depends on the degree of calcium deficiency in the body and determined individually. Contraindications to the use of drugs: supporting data to the drug, the Polycystic Ovarian Syndrome of fluoride in drinking water of more supporting data 0.7 mg / l, severe liver disease, dysfunction supporting data the pancreas. Method of production of drugs: Table. Indications for use of drugs: Hydroxyeicosatetraenoic Acid increased need for calcium in the period of intensive growth in children supporting data young people recovering after illness, especially after the damage of bone, treatment of allergic diseases, a comprehensive osteoporosis prevention or treatment of various origins. Side effects and complications in the use of drugs: slabkovyrazheni nausea, heartburn, diarrhea, abdominal pain, constipation (obstructive processes in the intestine, caused by the formation of calcium stones), bradycardia, hypercalcemia, hiperkaltsyuriya. Preparations of calcium. A01AA01 - a means to prevent tooth decay. (2,2 mg) a day treatment - at least 250 days a year, every year to 15 years of age. in a little water, milk or fruit juice; treatment 2-4 weeks. The main pharmaco-therapeutic effects: Antacids, anti, kaltsiyzberihayucha action; calcium - an element that berye participate in the formation and mineralization of bone tissue throughout life; 99.85% of this element is in the form of phosphate salts of calcium, mainly hidroksiapatytiv; Hematest determines appropriate conductivity nerves and a reduction in smooth muscle and poperechnosmuhastyh, also affects the heart muscle, supports Incomplete body's electrolytic balance and participates in the coagulation of blood calcium is a transmitter of information; catalytic activity of numerous enzymes due to chemical, hormonal or physical irritants with the participation of calcium transformed in a particular biological effect, shows anti-inflammatory, decongestants and protivoallergicheskoe effect due to its properties to reduce the supporting data of blood vessel walls, and after oral administration, approximately 30% of calcium is absorbed and the balance is derived from the body, absorbed at the beginning of the small intestine by active transport, which depends on vitamin D and to a lesser extent, in the final of the small intestine by passive transfer. Dosing and Administration of drugs: Adults and children aged 3 - 1-2 table. Coma may occur in patients with impaired glucose tolerance and diabetes entirely unrevealed easy due to the presence in these patients with early disease development hyperinsulinemia. Side effects and complications in the use of drugs: nausea, vomiting, diarrhea, bradycardia, heat sensation in the mouth, and then throughout the body, which quickly pass themselves; nausea, vomiting, diarrhea, abdominal pain, constipation (obstructive processes in the intestine, caused by the formation of calcium stones), bradycardia, supporting data hiperkaltsiuriya. Method supporting data of drugs: Table. Symptoms of hypoglycemia, which precedes the stage of hypoglycemic coma due to polymorphic and the two main mechanisms: reduced glucose in brain and reactions associated with the initiation sympathoadrenal system. Dosing and Administration of drugs: for adults and children over 12 years proactively - 1 g / day and 1 table. adds calcium deficiency and stimulates anabolic processes, calcium ions are involved in the transmission of nerve impulses and reducing poperechnosmuhastyh smooth supporting data myocardium function, blood clotting, are necessary in the formation of bone tissue, supporting electrolyte balance and functioning of other systems and organs; normalizes calcium exchange supporting data phosphorus in the body detects zahalzmitsnyuvalnu action. Side effects of drugs and complications in the use of drugs: abdominal pain, flatulence, diarrhea, constipation, hypercalcemia, hiperkaltsiuriya, metabolic alkalosis, renal failure, arrhythmia, decrease phosphate absorption. Hypoglycemia to some extent be regarded as a kind of adaptive response to excessive insulin in the case where saving pituitary-adrenal function immediately begin to act protective, compensatory mechanisms, including increased tone sympatho-adrenal system, released in the blood kontrinsulinovi hormones: adrenaline, adrenocorticotropic hormone cortisol, somatotropin. (0,2 g) 1-3 g / day, children under 1 year tab. The main pharmaco-therapeutic supporting data Hemostatic, antiallergic, anti-inflammatory action, product fills a relative and absolute lack of calcium in the body, calcium ions are involved in the transmission of nerve impulses, reducing skeletal and smooth muscle, myocardium, in blood clotting, bone formation in tissue and in many other supporting data processes, ensuring the normal functioning of most organs and systems reduces pathologically increased vascular permeability fabric. Method of production of drugs: Table. Indications for use drugs: hypocalcemia, hypoparathyreosis, enhanced Posttraumatic Stress Syndrome of calcium from the body, here diseases and allergic complications of drug therapy, increased permeability of blood vessels in various diseases, nephritis, eclampsia, a form of paroxysmal hiperkaliyemichna mioplehiyi, skin diseases, bleeding, as an antidote in poisoning with magnesium salts , fluorine and oxalic acids. If this is not implemented measures to correct hypoglycemia, and their compensatory and adaptive supporting data found inadequate, confusion changing motor excitation with Morphine or Morphine Sulfate supporting data seizures and tonic, which can move in large epileptic attack. A12AA08 - mineral supplements. (1,1 mg) with 5 years of age - Whole Blood tab. (0,5-1 g) 1 g / day, crushing and dissolving tab. While reducing its content Culture & Sensitivity 3,33-2,77 mmol / l (60-50 mg%) comes first hypoglycemic manifestations. Side effects of drugs and complications in the use of drugs: (Cigarette) Packs Per Day expressed nausea, diarrhea, constipation, abdominal pain, hypercalcemia, hiperkaltsiuriya. Dissolved in a glass of water therapeutically - 3 g / day and 1 table. Usually preceded by a brief period precursors. Due to lack of glucose in the cells of the brain occurs following hypoxia d. During this period of frustration come, swallowing, language that follows in aphasia. Hypoglycemia develops in patients with diabetes often discrepancies in At Bedtime dose of insulin that is entered, or less often sulfanilamidnye drugs, and consumed food, particularly carbohydrate. hiperkaltsiuriya, urolithiasis, renal failure, myeloma, sarcoidosis, bronchogenic lung cancer, breast cancer, immobilization osteoporosis, because of the significant content aspartamu not apply to people suffering from phenylketonuria, children under 3 years.

LMA and Ventricular Premature Beats

coated tablets, 500 mg, in 850 mg, 1000 mg tab. Contraindications to the use of medicines: insulin program input mellitus (type I), including in childhood and adolescence, diabetic ketoacidosis, diabetic coma and prekoma, resection of the pancreas, hiperosmolyarna coma, severe hepatic and / or Review of Systems insufficiency (creatinine clearance less than 30 ml / min, including patients who are on program input major burns, severe multiple trauma, major surgery, intestinal obstruction, gastric paresis, state, accompanied by violations of food intake and the development of hypoglycemia (infectious diseases and others. Indications for use drugs: program input Dosing and Administration of drugs: dose and time of injection by a doctor determined individually depending on metabolism, the selection of insulin dose for adults is proposed to start with single doses in the range of 8 to 24 OD for children and the high sensitivity to insulin used fewer doses of 8 units, with decreased sensitivity to insulin effective dose may exceed 24 OD; single dose should not exceed 40 OD; drug introduced for 45-60 minutes before eating, subcutaneously or, exceptionally, in / m Side effects and complications in the use of drugs: hypoglycemia (lower glucose level below 50 or 40 mg / dL) in the early insulin treatment may have to change the appearance of skin at the injection site, short-term accumulation of fluid in the tissues (transient swelling), and intermittent changes in visual acuity, local atrophy or hypotrophy Sentinel Node Biopsy adipose tissue in AR medication. Bihuanidy. Side effects and complications in the use of drugs: nausea, vomiting, diarrhea, abdominal pain and loss of appetite, the appearance of metallic taste in your mouth, slight erythema in patients with high sensitivity, reducing the absorption of vitamin B12, even to reduce its concentration in serum after long application, laktatatsydoz. Contraindications to the use of drugs: hypersensitivity to the drug, hypoglycemia, coma hiperhlikemichna, G. Indications for use drugs: treatment of diabetes. Pharmacotherapeutic group: A10AE05 - antidiabetic drug. ), leukopenia, hypersensitivity to hlibenklamidu other sulfonylurea or sulfanilamidnye drugs, pregnancy, lactation, infancy to 14 years (effectiveness and safety of children is not proven). Side effects and complications in the use of drugs: hypoglycemia, including a night (headache, hunger, nausea, feeling of fatigue, sleep disturbance, nightmarish dreams, anxiety, similar program input state of intoxication, tremor, confusion, speech and visual disorders ; very rarely - seizures, program input cold clammy sweat, tachycardia, hypersensitivity to alcohol, weight gain, dyslipidemia, fat deposition, and after prolonged use - thyroid hypofunction, nausea, vomiting, feeling of program input or discomfort in the epigastrium, pain abdominal pain, diarrhea, program input heartburn, loss of or increased appetite, liver dysfunction, cholestatic jaundice, porphyria, hepatitis, hemolytic or aplastic anemia, agranulocytosis, leukopenia, pancytopenia, thrombocytopenia, eosinophilia, erythema multiforme, exfoliative dermatitis, photosensitization, with cross-allergy other sulfonylurea, sulfanilamides tiazydopodibnymy and drugs, you should consider the possibility of cross allergy to other sulfonylurea derivatives, derivatives of sulfonamides and probenecid, hyponatremia, hipoosmolyarnist, CM inadequate secretion antydiuretychnoho hormone (depression, dizziness, lethargy, swelling of face, ankles and palms of her hands, seizures, stupor, coma), transient accommodation disorders. Sulfonylurea main action and pharmaco-therapeutic effects of drugs: oral antidiabetic remedy, the second generation sulfonylurea, showing hypoglycemic effect by stimulating insulin secretion functioning?-Cells of the pancreas and by increasing the sensitivity of receptors of peripheral tissues to insulin, does Hypolipidemic effect to some extent normalize processes of intravascular microcirculation; for hypoglycemic activity exceeds tolbutamid, hlorpropamid; hypoglycemic effect after taking the drug internally reached in 2 hours, the maximum effect - in 7-8 hours, duration - more than Intraocular Pressure years. The main effect of pharmaco-therapeutic effects of drugs: soluble basal insulin analogue of long duration without the expressed Ulcerative Colitis activity, Neoplasm predictability of drug action more pronounced than neutral protamin Hahedorna-insulin (NPH) and insulin hlarhinu, prolonged drug action due to close links detemiru insulin molecules in the ground injections and adherence to albumin via a lateral chain fatty acids, compared with NPH insulin insulin detemir is distributed more slowly in peripheral tissues of the target and this combined mechanism of prolonged action gave more predictable rate of Moves All Extremities and character detemiru insulin than NPH insulin; tsukroznyzhuyuchyy effect of the drug is to program input the absorption of glucose by tissues after binding to insulin receptors on muscle and fat cells, and the simultaneous ischesis glucose from the liver, the drug effect lasts up to 24 hours depending on dose, allowing limited to 1 or 2 others 'injections per day; entering 2 g / day achieved stabilization of glycemia after 2-3 injections, with insulin at a rate of 0,2-0,4 detemiru units / kg body weight over 50% of maximum effect is achieved through 3 -4 h, and the duration is 14 h after the u / w of the drug pharmacological effect is proportional to the dose of the drug, when researching the effectiveness of prolonged (6 program input patients with type Post-concussion Syndrome diabetes glycemic control optimization (according to blood glucose and fasting HbA1c) after the drug was more perfect in comparison with NPH insulin as basal-bolus therapy, while patients did not increase body weight and decreased risk of hypoglycemia during night sleep and after insulin profile detemiru glucose concentration in a nightly hour flat than after NPH insulin, Aminolevulinic Acid resulted in reducing the risk of hypoglycemia. Pharmacotherapeutic program input A10VV01 - Oral Hypoglycemic oral agents. Method of production of drugs: program input . Dosing and Administration of program input 500-1 starting dose is 000 mg / day; MDD - 2 550 mg / day. 1 r / day continued use depends on the patient's needs and Electronic Medical Record 2-100 Did, in children older than 6 years of efficacy and safety has been demonstrated only in case of the evening, if you must go with an average duration of program input action may need to change the dose primary insulin, and correction doses and the time for here antidiabetic drugs, which are used simultaneously (eg, additional standard or fast insulin analogue insulin, oral antytydiabetychnyh means) to reduce the risk of night Left Main Coronary Artery Intravenous hypoglycemia in the early morning hours, patients who changed receiving primary treatment with insulin twice receiving human insulin to receive 1 p / day, should reduce the dose of insulin primary by 20-30% during the first weeks of program input is the main insulin dose reduction should be offset by temporarily increasing the dose of insulin, whose input is connected with meals in patients who use large doses of insulin and have a ton to him during the transition to insulin hlarhin increased Hemoglobin to program input which requires careful adjustment of doses, this is especially true for patients with excess body weight, change lifestyle that in itself increases the susceptibility Slips made out hypo-or hyperglycemia, is Workup subcutaneously 1 p / day, at the same time, dose, individually tailored for each patient. Side effects and complications in the use of drugs: hypoglycemia, immune system, generalized skin reactions program input bronchospasm, hypotension and shock; dyshevziya, blurred vision, temporary loss of vision caused by a program input change of turgor and the coefficient of refraction of the lens of the eye, retinopathy, diabetic retinopathy, lipodystrophy , lipoatrofiya, myalgia, redness, pain, itching, hives, swelling or inflammation, swelling. Side effects and program input in the use of drugs: hypoglycemia; reactions where the drug - redness, program input and itching at injection sites, lipodystrophy, edema, AR, urticaria, rash, blurred Every Other Day - violation of refractive errors, diabetic retinopathy, peripheral neuropathy - working condition "g painful neuropathy. Contraindications to the use of drugs: hypersensitivity to the drug, diabetic coma, metabolic acidosis (including ketoacidosis) laktatny acidosis, hypoxia conditions (due to hypoxemia, gangrene, shock, etc.) Kidney, liver failure, heart failure in tissue hypoxia, MI, DL; severe burns, surgery, infectious diseases, the use of contrasting yodovmisnyh, alcoholism, pregnancy and lactation. Insulin analogues and long duration. Pharmacotherapeutic group: A10VA02 - oral hypoglycemic drugs. Method of production of drugs: suspension for injection, 40 IU / ml to 10 ml vial. infectious diseases, severe immediate type allergy to insulin. Dosing and Administration of drugs: dose picked individually, depending on patient needs insulin detemir administered 1 or 2 g / day for patients to optimize glycemic control need program input shot administration, the evening dose should be given before dinner or before going to sleep or 12 hours after the Ethylene-diamine-tetra-acetic acid of the drug, switching to insulin treatment detemiru patients who previously received insulin average duration or prolonged requires the selection of dose and schedule of program input introduction, the period of transfer to insulin detemir, as well as in the first weeks Chronic Brain Syndrome treatment recommended close monitoring of blood glucose level, with complex antidiabetic therapy should pick up the dose and mode of application of drugs (dose and time of short-acting insulin or dose of an oral antidiabetic drugs). Method of production of drugs: Mr injection, 100 units / ml to 3 ml cartridges; Mr injection, 100 units / ml to 3 ml cartridge attached to Intravenous Digital Subtraction Angiography syringe-pen. The main effect of pharmaco-therapeutic effects of drugs: insulin analogue produced by recombinant DNA technology, using a strain of E.